|
||
© The Rockefeller University Press,
0021-9525/1998//85 $5.00
The Journal of Cell Biology, Volume 141, Number 1,
, 1998 85-99
Regular Articles |
Dynamin-mediated Internalization of Caveolae


,
Department of Biochemistry and Molecular Biology, and
Center for Basic Research in Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905
The dynamins comprise an expanding family of ubiquitously expressed 100-kD GTPases that have been implicated in severing clathrin-coated pits during receptor-mediated endocytosis. Currently, it is unclear whether the different dynamin isoforms perform redundant functions or participate in distinct endocytic processes. To define the function of dynamin II in mammalian epithelial cells, we have generated and characterized peptide-specific antibodies to domains that either are unique to this isoform or conserved within the dynamin family. When microinjected into cultured hepatocytes these affinity-purified antibodies inhibited clathrin-mediated endocytosis and induced the formation of long plasmalemmal invaginations with attached clathrin-coated pits. In addition, clusters of distinct, nonclathrin-coated, flask-shaped invaginations resembling caveolae accumulated at the plasma membrane of antibody-injected cells. In support of this, caveola-mediated endocytosis of labeled cholera toxin B was inhibited in antibody-injected hepatocytes. Using immunoisolation techniques an anti-dynamin antibody isolated caveolar membranes directly from a hepatocyte postnuclear membrane fraction. Finally, double label immunofluorescence microscopy revealed a striking colocalization between dynamin and the caveolar coat protein caveolin. Thus, functional in vivo studies as well as ultrastructural and biochemical analyses indicate that dynamin mediates both clathrin-dependent endocytosis and the internalization of caveolae in mammalian cells.
Abbreviations used in this paper: Dyn1/2/3, dynamin I/II/III; GPI, glycosylphosphatidylinositol; HLA, human leukocyte antigen; pIgA-R, polymeric IgA receptor.
EUKARYOTIC cells internalize plasma membrane, surface receptors, and small molecules via several distinct endocytic processes (reviewed in Anderson et al., 1992; Anderson, 1993c; Goldstein et al., 1985; Watts and Marsh, 1992; van Deurs et al., 1993; Sandvig and van Deurs, 1994; Lamaze and Schmid, 1995). The most characterized process is receptor- or clathrin-mediated endocytosis (Anderson et al., 1977; Goldstein et al., 1979), which uses a clathrin and adaptor protein complex to sequester receptors and associated ligands into 100–150-nm-diam coated pits at the plasma membrane (reviewed in Goldstein et al., 1985; Pearse and Robinson, 1990). Recently, a more enigmatic endocytic process has been studied whereby cells internalize certain glycosylphosphatidylinositol (GPI)1-linked proteins, albumin, bacterial toxins, class I human leukocyte antigen (HLA), viruses, and small proteins (e.g., Huet et al., 1980; Kartenbeck, et al., 1989; Parton et al., 1994; Predescu et al., 1994, 1997; Schnitzer et al., 1994, 1996; Smart et al., 1994, 1995; Stang et al., 1997). This pathway, which is clearly distinct from clathrin-mediated endocytosis, relies on flask-shaped, nonclathrin-coated, 50–85-nm-diam plasmalemmal vesicles called caveolae (e.g., Palade, G.E. 1953. J. Appl. Physics. 24:1424 (Abstr.); Palade and Bruns, 1968; Rothberg et al., 1992; Yamada, 1955). The molecular mechanisms by which these distinct plasmalemmal invaginations are severed to produce endocytic vesicles both require GTP hydrolysis, yet remain largely undefined (Carter et al., 1993; Schnitzer et al., 1996). Whereas the dynamins have been implicated in the scission of clathrin-coated vesicles from the plasma membrane (Takei et al., 1995; reviewed in De Camilli et al., 1995), it is unknown how caveolae and noncoated plasmalemmal invaginations detach to form free endocytic vesicles.
The dynamins are a multigene family of large (100-kD) GTPases that were originally identified in the brain (Shpetner and Vallee, 1989) and, more recently, have been implicated in endocytosis (reviewed in De Camilli et al., 1995; Robinson et al., 1994; Urrutia et al., 1997; Warnock and Schmid, 1996). Seminal studies on the paralytic shibirets1 mutants of Drosophila melanogaster (Grigliatti et al., 1973), which express a temperature-sensitive mutation in the GTP-binding domain of the fly dynamin (Chen et al., 1991; van der Bliek and Meyerowitz, 1991), revealed dramatic ultrastructural alterations of the plasma membrane in both neuronal and epithelial cells (reviewed in Urrutia et al., 1997). At the restrictive temperature, nerve terminals of paralyzed flies are depleted of synaptic vesicles and accumulate short, nonclathrin-coated, "collared" pits at the plasma membrane, consistent with a defect in the endocytic retrieval of synaptic vesicle membrane (Koenig and Ikeda, 1989; Kosaka and Ikeda, 1983a; Poodry and Edgar, 1979). In contrast, epithelial cells of paralyzed flies contain numerous long plasmalemmal invaginations attached to clathrin-coated pits, suggesting an impairment of clathrin-mediated endocytosis (Kessel et al., 1989; Koenig and Ikeda, 1990; Kosaka and Ikeda, 1983b). These observations are supported by more recent studies on mammalian cells overexpressing a mutant dynamin, in which clathrin-mediated endocytosis is impaired (Herskovitz et al., 1993; van der Bliek et al., 1993; Damke et al., 1994, 1995), leading to the formation of long plasmalemmal invaginations that are similar to those observed in epithelial cells from the shibirets1 mutants (Damke et al., 1994). Further characterization of these transfected cells showed that fluid-phase endocytosis is not inhibited (Herskovitz et al., 1994; Damke et al., 1994) but upregulated over time, possibly to compensate for the inhibition of clathrin-mediated endocytosis (Damke et al., 1995). This change in fluid-phase endocytosis is particularly surprising when compared with cells of the shibirets1 mutants, in which both clathrin-mediated endocytosis and fluid-phase endocytosis are inhibited at the restrictive temperature (Kessel et al., 1989; Kosaka and Ikeda, 1983a,b). Thus, it is currently unclear whether the dynamins participate solely in one or several endocytic processes. It has been hypothesized that multiple dynamin isoforms may perform a variety of endocytic functions (Artalejo et al., 1995; Urrutia et al., 1997).
Three distinct dynamin genes have been identified in mammals. Dynamin I (Dyn1) is expressed exclusively in neurons (Obar et al., 1990), dynamin II (Dyn2) is found in all tissues (Cook et al., 1994; Sontag et al., 1994), and dynamin III (Dyn3) is restricted to the testis, the brain, the lung, and the heart (Cao, H., and M.A. McNiven, manuscript in preparation; Cook et al., 1996; Nakata et al., 1993). Each dynamin gene encodes four or more alternatively spliced isoforms (reviewed in Robinson et al., 1994; Urrutia et al., 1997). Thus, all cells coexpress at least four Dyn2 isoforms, and neurons may express 12 or more distinct dynamins. Additional unidentified dynamin family members are likely to exist as well. It is unclear if the different dynamin gene products perform redundant functions or participate in distinct endocytic processes. To date, the important studies on cultured mammalian cells have overexpressed a mutant Dyn1 isoform in epithelial cells that do not normally express Dyn1 but rather four isoforms of Dyn2 (Damke et al., 1994, 1995; Herskovitz et al., 1993; van der Bliek et al., 1993). Therefore, the resulting phenotype that is observed in these cells may provide only a partial view of the cellular processes in which the endogenous dynamins are involved.
The focus of this study was to extend the observations described above and define the function of a single dynamin family member in mammalian epithelial cells. To this end, we generated antibodies to peptides representing a conserved domain of the dynamin family and to a second region that is specific to the ubiquitously expressed Dyn2. Our goal was to test the effects of these affinity-purified antibodies on distinct endocytic processes and plasmalemmal morphology when injected into cultured mammalian epithelial cells. We found that two of these anti-dynamin antibodies inhibited the cellular uptake of fluorescent transferrin conjugates and induced the formation of long clathrin-coated invaginations from the plasma membrane, consistent with the shibirets1 phenotype and the observations from epithelial cells overexpressing a mutant Dyn1 isoform. In addition to these long clathrin-coated membranes in the anti-dynamin antibody-injected cells, we observed numerous, nonclathrin-coated, flask-shaped structures resembling caveolae that accumulated at the plasma membrane. The density of these plasmalemmal invaginations was increased significantly in the anti-dynamin antibody-injected cells compared with controls. Strikingly, these caveolar profiles frequently formed large, aberrant, grape-like clusters that extended deep within the cytoplasm. To determine if these structures represented a perturbation of normal caveolar function, we showed that the internalization of fluorescein-labeled cholera toxin B (FITC-cholera toxin B), which normally is mediated by caveolae, was inhibited in anti-dynamin antibody-injected cells. Electron microscopy confirmed that HRP-labeled cholera toxin B (HRP-cholera toxin B) remained concentrated in plasmalemmal caveolae in these inhibited cells and did not gain access to cytoplasmic organelles. To verify that dynamin associates with caveolae, an anti-dynamin antibody was used to immunoisolate caveolar membranes from a subcellular postnuclear membrane fraction. In addition, double label immunofluorescence microscopy of cultured hepatocytes revealed a significant overlap between dynamin and caveolin. These results demonstrate that Dyn2 participates in an additional endocytic process that is distinct from clathrin-mediated endocytosis and provide insight into the molecular mechanisms governing the GTP-mediated internalization of caveolae.
| Materials and Methods |
|---|
|
|
|---|
|
-adaptin as well as FITC– and HRP–cholera toxin B were from Sigma Chemical Co. (St. Louis, MO).
|
For immunoprecipitations, brains from male Sprague Dawley rats were homogenized as described above in 4 vol of 4°C RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS) containing protease inhibitors. The homogenate was centrifuged as above and the supernatant collected as the clarified extract. Appropriate antibodies (5 µg) were incubated with 1-ml fractions (15–25 mg) of the clarified extracts, and then preswollen protein A beads (5 mg) were added before a second incubation. Incubations were 2–12 h at 4°C with rotation. Beads and immune complexes were collected by centrifuging 3 min at 7,000 g and then rinsed 4 x 5 min with the starting buffer before being subjected to SDS-PAGE and Western blot analysis.
Immunoisolations were done as reviewed by Howell et al. (1989). To prepare the starting membrane fraction, confluent cultures of hepatocytes (
600 cm2)were scraped into 4°C buffer A containing protease inhibitors and homogenized by sonication. The homogenate was centrifuged 10 min at 1,000 g to obtain a postnuclear supernatant that then was centrifuged 1 h at 100,000 g to collect the pellet as the postnuclear membrane fraction. This postnuclear membrane fraction was resuspended gently in PBS-FBS (8.1 mM NaHPO4, 1.2 mM KH2PO4, pH 7.2, 138 mM NaCl, 2.7 mM KCl, 2 mM EDTA, 0.9 mM CaCl2, 0.5 mM MgCl2, and 5% FBS). Affinity-purified anti-Pan61 antibody, or the anti–pIgA-R antibody as a control, were linked to Dynabeads M-500 Subcellular superparamagnetic beads (Dynal, Inc., Lake Success, NY) as described previously (Henley and McNiven, 1996). The appropriate antibody-coated beads (10 mg) and 0.5–2.0 mg of the starting membrane fractions were incubated
8 h at 4°C with rotation in 1 ml of PBS-FBS. The beads and any bound membranes then were collected with a magnet, rinsed three times with PBS-FBS, and subjected to SDS-PAGE and Western blot analysis.
The protein concentration of each cellular extract was determined using bicinchoninic acid, as per instructions from the manufacturer (Pierce Chemical Co., Rockford, IL). For Western blot analysis, cellular protein extracts and immune complexes were reduced in sample buffer (62.5 mM Tris, pH 6.8, 5% glycerol, 4% β-mercaptoethanol, 2% SDS, and 4 µg/ml bromophenol blue), separated by discontinuous SDS-PAGE (Laemmli, 1970) and electrophoretically transferred to polyvinyldifluoridine filters (Towbin et al., 1979). Filters containing transferred proteins were incubated with appropriate primary antibodies (0.5–1 µg/ml) and then HRP-conjugated secondary antibodies (0.5–1 µg/ml), as reported previously (Henley and McNiven, 1996). Reactive bands were visualized by exposing the filters to autoradiographic film (Eastman Kodak Co., Rochester, NY) after using enhanced chemiluminescence detection reagents (Amersham Corp., Arlington Heights, IL) as per instructions from the manufacturer. Developed autoradiographs were subjected to densitometric analysis using a Bio-Rad imaging densitometer (Model GS-700) and Molecular Analyst software (Bio-Rad Laboratories).
Microinjections
Microinjections were done on a 37°C microscope stage and cells were allowed to recover 2–6 h before subsequent manipulations. Cells were pressure injected using an IM-200 microinjector system (Narishige USA, Inc., Greenvale, NY) and microneedles that were pulled from thin-wall (1.0-mm outer diam; 0.78-mm inner diam) borosilicate tubing (with filament) using a Flaming/Brown P-97 micropipette puller (Sutter Instrument Co., Novato, CA). Injected antibodies were purified anti-Pan65, anti-Dyn2T, or irrelevant anti-kinesin antibodies that were dialyzed and concentrated (2–15 mg/ml) in microinjection buffer (10 mM KH2PO4, pH 7.2, and 75 mM KCl) using 30-kD molecular mass cut off Nanosep Microconcentrators (Pall Filtron Corp., Northborough, MA). For additional control injections, the anti-Pan65 and anti-Dyn2T antibodies were heat inactivated by incubating 5 min at 100°C. Cascade blue hydrazide (2.5 mM) or fluorescent dextran conjugates (400 µM) were added to all microinjection solutions. This served as an indicator for successful microinjections and enabled injected cells to be identified readily by fluorescence microscopy after functional assays were performed. For experiments where electron microscopy would be used, it was necessary to inject every cell within a particular square (1 mm2) of the gridded coverglass. In some of these experiments colloidal gold (5-nm diam) was included in the injection solution to identify injected cells by electron microscopy.
Functional Assays
As a measure of clathrin-mediated endocytosis, the cellular internalization of rhodamine-, fluorescein-, or Texas red–labeled transferrin was assayed. First, cells were rinsed with 37°C HBSS (Sigma Chemical Co.) and incubated in DME containing 2% defatted BSA (DME-BSA) to remove unlabeled transferrin. Cells then were incubated 15 min at 37°C in DME-BSA containing 5 µg/ml of an appropriate fluorescent transferrin conjugate to allow internalization. Finally, cells were rinsed twice with 4°C DME-BSA (adjusted to pH 3.5 with acetic acid) and four times with HBSS to remove surface labeling and then processed for fluorescence microscopy.
To assay caveola-mediated endocytosis, the internalization of FITC– or HRP–cholera toxin B was monitored by fluorescence or electron microscopy, respectively. Cells were rinsed with HBSS and incubated in DME-BSA as above, then chilled to 4°C and incubated 15 min in DME-BSA containing 4 µg/ml FITC– or HRP–cholera toxin B. Labeled cells were rinsed four times with 4°C HBSS to remove unbound toxin. These cells then were incubated
2.5 h in DME-BSA at 37° C to allow internalization and appropriately fixed. For double labeling experiments, 5 µg/ml Texas red–labeled transferrin was included during the last 15 min of the 2.5 h internalization incubation at 37°C before rinsing the cells as in the assay for clathrin-mediated endocytosis.
Fluorescence Microscopy
Labeled cells were rinsed briefly with 37°C PBS (8.1 mM NaHPO4, 1.2 mM KH2PO4, pH 7.2, 138 mM NaCl, 2.7 mM KCl, 0.9 mM CaCl2, and 0.5 mM MgCl2), submerged in 37°C fixative (100 mM Pipes, pH 6.95, 3 mM MgSO4, 1 mM EGTA, and 2.5% formaldehyde) and incubated 20 min at room temperature. For indirect immunocytochemistry, fixed cells were permeabilized with PBS containing 0.1% Triton X-100 and then incubated with antibodies as described (Henley and McNiven, 1996). Cells were rinsed three times with PBS and once with distilled water, then they were mounted in SlowFade or ProLong antifade reagents. Digital images were acquired using an intensified charged coupled device camera (XC-77; Hamamatsu Photonics K.K., Hamamatsu City, Japan) or a cooled charged coupled device camera (SenSys; Photometrics, Tucson, AZ) attached to a Zeiss Axiovert 35 microscope that was equipped with a mercury arc (50 or 100 W). A laser scanning confocal microscope (LSM-410; Carl Zeiss, Inc.) also was used. Acquired images were manipulated with Image-1 and Metamorph software (Universal Imaging Corp., West Chester, PA) then stored on a computer hard drive. Alternatively, photographic images were recorded on Kodak film (Ektachrome, 400 ASA or Tmax, 3200 ASA) using a 35-mm camera attached to the microscope, and the images were digitized using a SprintScan 35 slide scanner (CS-2700; Polaroid Corp., Cambridge, MA) and Adobe Photoshop software (Adobe Photosystems, Inc., Mountain View, CA).
Electron Microscopy
For conventional electron microscopy, cells were rinsed with 37°C PBS, submerged in 37°C primary fixative (100 mM cacodylate, pH 7.4, 60 mM sucrose, 2.5% glutaraldehyde) and incubated 1 h at room temperature. Cells then were incubated 1 h at room temperature in 1% osmium tetroxide. Fixed cells subsequently were incubated 1 h at room temperature in 1% uranyl acetate, dehydrated in a graded series of ethanol, and embedded in Quetol 651 (Ted Pella, Inc., Redding, CA). To make the plasma membrane electron dense, 1 mg/ml ruthenium red was included in the primary fixative and in the 1% osmium tetroxide solution, and cells were osmicated an additional 2 h. For the cytochemical detection of HRP, cells were rinsed, incubated 30 min in the fixative (100 mM cacodylate, pH 7.4, 100 mM sucrose, 0.5% glutaraldehyde) and then reacted with 1 mg/ml diaminobenzidine and 0.012% hydrogen peroxide for 15 min. Cells then were rinsed, incubated 1 h in 1% osmium tetroxide and 1.5% potassium ferricyanide and processed for electron microscopy as above.
After the embedding, the carbon interface enabled the underlying gridded coverglass to be separated readily from the embedded cells, leaving an imprint of the grid on the block face. This allowed the block face to be trimmed so that only the 1-mm2 square containing the injected cells remained. Thin sections (0.09–0.1 µm) were cut parallel to the ventral surface of the cells using a diamond knife (Diatome U.S., Fort Washington, PA) and an Ultracut E microtome (Reichert-Jung, Wien, Austria). Sections were collected on copper grids, post-stained with lead citrate and viewed at
60 kV with a JEOL 1200 transmission electron microscope (JEOL USA, Peabody, MA).
Quantitative and Statistical Analyses
All quantitation and stereology were done in a blinded fashion using standard techniques. The results presented (see Figs. 3 and 7; Tables I and II) are averages of data sets that were obtained by at least two of the authors who conducted these experiments in parallel. Quantitation of plasmalemmal invaginations and the surface density of caveolae was performed on electron micrographs of entire cell profiles. Micrographs were printed at a magnification of 4,000–12,000. To quantify the amount of invaginated plasma membrane, an overlay grid was used to count the number of points falling on ruthenium red–stained membranes relative to the number of points within the confines of the cell. A hand held magnifier (3x) aided in the identification of internal ruthenium red–stained membranes. Caveolae were defined by morphological criteria as plasmalemmal vesicles between 50 and 80 nm in diameter that lacked any obvious cytoplasmic coats. To determine the surface density of caveolae, we counted the number of ruthenium red–stained caveolae per cell that were within 50 nm of the plasma membrane. The perimeter of each cell then was traced on a digitizing pad and converted to micrometers using an NIH Image 1 software package (National Institutes of Health, Bethesda, MD). From these values we calculated the number of caveolae/µm/cell. Results from the studies are expressed as the median ± SEM for each data set. Significance levels were determined by the Wilcoxin rank sum statistical analysis, as described in the footnotes to Tables I and II.
|
|
|
|
| Results |
|---|
|
|
|---|
100 kD by Western blot analysis of a rat liver cytosolic fraction (Fig. 1 b) and complete lysates of cultured murine hepatocytes and human skin fibroblasts (data not shown). Although an
87 kD-band also was detected with the anti-Pan65 antibody in some preparations, the anti-Dyn2T antibody was specific for dynamin and did not cross react with unrelated proteins (Fig. 1 b and data not shown). The dynamin band was not detected with a previously characterized antibody that is specific for Dyn1 (Henley and McNiven, 1996), since Dyn1 is not expressed in epithelial cells (Fig. 1 b; Cook et al., 1994; Sontag et al., 1994). Finally, the control anti-kinesin antibody recognized a characteristic
120 kD-band, but not the dynamin band (Fig. 1 b). To test for isoform specificity, these antibodies were used to immunoprecipitate dynamin from the brain, a tissue that expresses all of the known dynamin isoforms. The immune complexes were subjected to SDS-PAGE and Western blot analysis with the purified isoform-specific antibody to Dyn1 and the anti-Dyn2T antibody. As expected, the anti-Pan61 and anti-Pan65 antibodies each coprecipitated Dyn1 and Dyn2, whereas the anti-Dyn2T antibody recognized Dyn2 predominantly and precipitated only trace amounts of Dyn1 (Fig. 1 c). Based on these results, the antibody reagents used in this study are predicted to provide specific tools to test the function of dynamin in vivo.
Antibodies to Dynamin Inhibit Clathrin-mediated Endocytosis
To directly test the function of dynamin in endocytic processes, we injected cultured murine hepatocytes with the anti-Pan65 and anti-Dyn2T antibodies or the respective heat-inactivated antibodies and an anti-kinesin antibody as controls. Because dynamin has been implicated in clathrin-mediated endocytosis, we first assayed whether injected cells could internalize rhodamine-labeled transferrin (rhodamine-transferrin). This ligand is endocytosed by a clathrin-mediated pathway (Hopkins and Trowbridge, 1983; Sager et al., 1984) and has been used previously to assess the function of dynamin (Damke et al., 1994, 1995; van der Bliek et al., 1993). As shown in Fig. 2, cells injected with the heat-inactivated antibodies endocytosed rhodamine- transferrin, as did the adjacent uninjected cells. Cells injected with the anti-kinesin antibody also internalized the fluorescent ligand (data not shown, but see Fig. 3). In contrast, clathrin-mediated endocytosis was inhibited in cells that were injected with the native affinity-purified anti-Dyn2T antibody as assessed by the lack of internal rhodamine-transferrin fluorescence. Identical results were obtained in cells that were injected with the anti-Pan65 antibody. The effects of these antibody injections on clathrin-mediated endocytosis were quantitated by determining the percentage of injected cells that internalized rhodamine-transferrin (Fig. 3). As expected, we found that 77–90% of the control anti-kinesin and heat-inactivated antibody injected cells endocytosed fluorescent transferrin conjugates. In contrast, only 8–16% of the anti-Pan65 and anti-Dyn2T antibody-injected cells internalized the ligand, consistent with a greater than fourfold decrease in clathrin-mediated endocytosis.
|
|
|
|
S. The anti-dynamin antibody-injected cells also were devoid of internal Texas red–transferrin fluorescence, which indicates that both the internalization of caveolae and clathrin-mediated endocytosis were inhibited and demonstrates that Dyn2 participates in distinct endocytic processes in the same cell (Fig. 6). Control experiments where uninjected cells first were depleted of postassium for 2.5 h to inhibit clathrin-mediated endocytosis (Larkin et al., 1983, 1985) before the assays support the existence of these two distinct endocytic pathways in the cultured hepatocytes: FITC–cholera toxin B still was internalized normally, whereas Texas red–transferrin was not (data not shown).
|
88% of the anti-kinesin and heat-inactivated antibody-injected cells internalized FITC–cholera toxin B, this percentage dropped significantly to <20% of the cells that were injected with the anti-Pan65 and anti-Dyn2T antibodies. Thus, caveola-mediated endocytosis is reduced greater than fourfold in the anti-dynamin antibody-injected cells. To support these findings, we examined the antibody-injected cells by electron microscopy after labeling them with HRP–cholera toxin B. First, cultured hepatocytes were injected with the anti-Pan65 and anti-Dyn2T antibodies or heat-inactivated antibodies as a control. Then cells were incubated with HRP–cholera toxin B as in the fluorescence assay, fixed, and processed for the cytochemical detection of peroxidase. The typical localization of internalized HRP–cholera toxin B in hepatocytes injected with a heat-inactivated antibody is illustrated in Fig. 8 a. By electron microscopy, peroxidase labeling was present in numerous endosomal structures, elements of the rough endoplasmic reticulum and the nuclear envelope, with negligible staining of the plasma membrane. A similar localization was found in the uninjected cells (data not shown). This internal distribution of the toxin conjugate is consistent with numerous reports from others using multiple cell types (Joseph et al., 1979; Montesano et al., 1982; Tran et al., 1987; Parton, 1994; Sandvig et al., 1996). In contrast, cells injected with the anti-Pan65 (Fig. 8 b) and anti-Dyn2T (data not shown) antibodies did not contain internal peroxidase reaction product. Instead, HRP–cholera toxin B labeling remained at the plasma membrane where it was concentrated in nonclathrin-coated caveolar profiles and grape-like caveolar clusters (Fig. 8, c and d). Little, if any labeling was detected in the endosomes, the endoplasmic reticulum, or the nuclear envelope. Thus, the anti-dynamin antibody-injected cells were able to sequester HRP–cholera toxin B within plasmalemmal caveolae but were unable to complete the internalization process. These ultrastructural studies support the earlier fluorescence assay (see Figs. 6 and 7) and morphological observations (see Fig. 5 and Table II), confirming that Dyn2 participates in the caveola-mediated endocytosis of cholera toxin B.
Dynamin Associates with Caveolae
To verify that dynamin was present on caveolar membranes, we first performed immunoisolation experiments using the anti-Pan61 antibody and a control polyclonal antibody to the pIgA-R (Henley and McNiven, 1996). Antibodies were linked to paramagnetic beads and then incubated with a postnuclear membrane fraction that was obtained from the same cultured murine hepatocytes used throughout this study. Immunobeads and bound membranes were collected with a magnet, rinsed, and then subjected to SDS-PAGE and quantitative Western blot analysis using antibodies to the caveolar membrane protein caveolin (Rothberg et al., 1992; Dupree et al., 1993), the integral plasmalemmal Na+/K+ ATPase (Shyjan and Sevenson, 1989), or the
subunit of the AP-2 adaptor complex. Fig. 9 illustrates that caveolin is expressed in the cultured hepatocytes and was detected readily in the starting postnuclear membrane fraction (Fig. 9, a, top and b, lane 1). Significantly, the material isolated with the anti-Pan61 antibody contained substantial caveolin immunoreactivity, indicating that dynamin associates with caveolar membranes (Fig. 9, a, top and b, lane 2). This association was prominent, since the anti-Pan61 antibody depleted most of the caveolin that was present in the starting membrane fraction (Fig. 9, a, top and b, lane 3). In contrast, caveolar membranes were not isolated by the control anti–pIgA-R antibody since only trace amounts of caveolin were found in this immunoisolated fraction (Fig. 9 a, top and b, lane 4) and, as expected, most of the caveolin immunoreactivity remained in the fraction that did not bind to this antibody (Fig. 9, a, top and b, lane 5). Also significant is the finding that neither the Na+/K+ ATPase nor the AP-2 adaptor complex were enriched in the anti-Pan61 immunoisolated fraction compared with the anti–pIgA-R immunoisolated fraction. This indicates that the caveolar membranes were isolated directly and not by an indirect interaction with the plasma membrane or clathrin-coated pits (Fig. 9 a, middle and bottom). Immunoisolations done using a postnuclear membrane fraction from cultured human fibroblasts gave similar results, indicating that the association of dynamin with caveolae is not unique to the hepatocyte cell line used in this study (data not shown).
To complement the immunoisolation experiments described above, double label immunofluorescence microscopy of cultured hepatocytes was performed. Fixed cells were processed for indirect immunocytochemistry using a monoclonal anti-caveolin antibody to label caveolae and the polyclonal anti-Pan61 antibody to localize the endogenous dynamin. Representative micrographs obtained by confocal laser scanning microscopy are shown in Fig. 10 and demonstrate the significant overlap of the two staining patterns. Although some of the caveolin and dynamin labeling remains separate, a striking colocalization on peripheral vesicles indicates that a population of caveolae is positive for dynamin. The dynamin immunoreactivity that is distinct from the caveolin labeling most likely represents a localization to clathrin-coated membranes, since double labeling with antibodies to dynamin and clathrin reveals a significant colocalization (data not shown; but see Jones et al., 1998). These results are consistent with the biochemical data presented in Fig. 9 and support the body of evidence indicating that dynamin mediates the scission of caveolae from the plasma membrane in addition to its role in clathrin-mediated endocytosis.
|
| Discussion |
|---|
|
|
|---|
Specificity of the Anti-dynamin Antibodies Used in This Study
This investigation used distinct anti-dynamin antibodies to inhibit the function of Dyn2 in living cells. To increase the probability of a specific functional inhibition, we used affinity-purified anti-peptide antibodies that were made to two distinct regions of Dyn2. The anti-Pan61 and anti-Pan65 antibodies are to an NH2-terminal domain that is conserved among the dynamin family, whereas the anti-Dyn2T antibody is to a COOH-terminal region that is unique to Dyn2 (Cook et al., 1994; Sontag et al., 1994). Each of the antibodies recognized a prominent
100-kD dynamin band by Western blot analysis. We view these antibodies as remarkably sensitive and specific considering that dynamin is expressed in the liver at low levels. Indeed, few antibodies to date are able to recognize endogenous dynamin in nonneuronal cells, which is why dynamin once was considered to be brain-specific (Nakata et al., 1991; Scaife and Margolis, 1990). Of the protein sequences that are listed in the Genbank and Swiss-Prot databases, Dyn1 is the most similar to Dyn2, sharing 26–42% identity within the tail region to which the anti-Dyn2T antibody was made. Significantly, the anti-Dyn2T antibody immunoprecipitated only trace amounts of Dyn1 from the brain, and, therefore, most likely interacts exclusively with Dyn2 when injected into cultured hepatocytes. Importantly, in this study similar results were obtained with either of the native anti-Pan65 and anti-Dyn2T antibodies but not with antibodies that were heat inactivated before injection to control for artifacts resulting from the injection procedure or from incomplete dialysis of the antibody solutions. In addition, we injected an irrelevant antibody to the vesicle-associated enzyme kinesin at a similar concentration as the anti-dynamin antibodies to control for nonspecific effects of injected antibodies.
Whereas the anti-Pan61 antibody was very efficient at immunoisolating caveolar membranes from a starting postnuclear membrane fraction, the anti-Pan65 and anti-Dyn2T antibodies were not. Future detailed biochemical studies will address whether the epitopes recognized by the anti-Pan65 and anti-Dyn2T antibodies are masked by interactions between the dynamin isoforms and target proteins or membranes. Importantly, however, immunofluorescence microscopy with the anti-Pan65 antibody gave a punctate labeling pattern that overlapped significantly with the caveolin labeling, similar to the anti-Pan61 antibody (data not shown, but see Fig. 10).
Role of Dyn2 in Distinct Endocytic Processes
In this report we provide morphological evidence that indicates distinct endocytic structures accumulate in anti- dynamin antibody-injected cells. The long clathrin-coated invaginations identified by electron microscopy are characteristic of an inhibition of clathrin-mediated endocytosis (Kosaka and Ikeda, 1983b; Damke et al., 1994, 1995; Kessel et al., 1989; Koenig and Ikeda, 1990; Shupliakov et al., 1997). However, the marked accumulation of aberrant clusters of nonclathrin-coated, 65–75-nm-diam plasmalemmal vesicles resembling complexes of caveolae, and the dramatic increase in the surface density of caveolae are consistent with defective severing of these endocytic organelles from the plasma membrane (Schnitzer et al., 1996). Caveolae contain a cytoplasmic coat that is not resolved readily by conventional transmission electron microscopy but can be detected by high resolution scanning electron microscopy or rapid freezing techniques (Peters et al., 1985; Rothberg et al., 1992). The integral membrane protein caveolin, also known as VIP21 (Glenney and Zokas, 1989; Glenney and Soppet, 1992; Kurzchalia et al., 1992), is a component of this cytoplasmic coat (Rothberg et al., 1992; Dupree et al., 1993) and is necessary and sufficient for the de novo generation of caveolae (Chung, K.N., P.C. Elwood, and J.E. Heuser. 1996. Mol. Biol. Cell. 7:277a. (Abstr.); Fra et al., 1995). This coat likely is responsible for generating the force for curvature of the plasma membrane and imparting the characteristic flask shape and 50–85 nm diam to caveolar buds. This study demonstrates that a functional dynamin isoform then is necessary for the scission of these plasmalemmal invaginations to form free internalized caveolae. Identifying other components of a "scission complex" that may coassociate with Dyn2 and caveolar membranes will be of great interest for future studies.
Until recently, it was presumed that caveolae were permanent fixtures of the plasma membrane (Bundgaard et al., 1979; Frøkjaer-Jensen et al., 1988; reviewed in Severs, 1988; van Deurs et al., 1993). This feature made the function of caveolae difficult to predict, although a role in the uptake of small molecules, or potocytosis, has been described (reviewed in Anderson, 1993c). Others have hypothesized a role in cellular signal transduction (reviewed in Anderson, 1993a,b; Lisanti et al., 1994) and calcium homeostasis (Fujimoto, 1993; Schnitzer et al., 1995b). Recently, several studies have provided persuasive evidence that caveolae actively sequester and internalize specific lipids, proteins, and associated ligands through an endocytic process (reviewed in Lamaze and Schmid, 1995; Parton and Simons, 1995). Certain glycosphingolipids, including GM1 gangliosides, are enriched in vitro in nonionic detergent-resistant membrane fractions that are similar to isolated caveolar fractions (e.g., Brown and Rose, 1992; Dupree et al., 1993; Fiedler et al., 1993; Kurzchalia et al., 1992; Schnitzer et al., 1995a). Many other studies have reported that the B subunit of cholera toxin, which specifically binds to GM1 gangliosides, is concentrated and internalized via nonclathrin-coated pits and vesicles that are distinct from those that are associated with clathrin-mediated endocytosis (Montesano et al., 1982; Tran et al., 1987; Parton, 1994; Schnitzer et al., 1996). Recently, Parton (1994) convincingly showed that cholera toxin is internalized via a caveola-mediated process but is not enriched in clathrin-coated pits and vesicles. In support of this, we found that inhibiting clathrin-mediated endocytosis in cultured hepatocytes by potassium depletion did not prevent the internalization of a fluorescent cholera toxin B conjugate (data not shown). These distinct endocytic pathways have different kinetics, with clathrin-mediated endocytosis occurring fourfold faster than internalization by caveolae (e.g., Fishman, 1982a; Tran et al., 1987). The protein phosphatase inhibitor okadaic acid stimulates caveola-mediated endocytosis, but inhibits the formation of clathrin-coated vesicles (Parton et al., 1994). Furthermore, the sterol-binding agent filipin has no affect on clathrin-mediated endocytosis yet inhibits the internalization of caveolae (Schnitzer et al., 1994). Finally, activators of protein kinase C, which do not inhibit clathrin-mediated endocytosis, prevent the formation of caveolar invaginations (Smart et al., 1994, 1995).
GTP hydrolysis is necessary for the severing of caveolar invaginations to produce discrete endocytic vesicles that are detached from the plasma membrane (Schnitzer et al., 1996). Thus, the internalization of caveolae in this respect is analogous to clathrin-mediated endocytosis, which uses the cytoplasmic coat protein clathrin to form invaginations of a characteristic size and relies on a GTP-dependent scission event to form discrete coated vesicles from the plasma membrane (Carter et al., 1993; reviewed in Robinson, 1994). Here we have shown that these two distinct pathways use the large GTPase dynamin to regulate the formation of free endocytic vesicles from specialized invaginations of the plasma membrane.
The functional experiments described here, in which the microinjected anti-dynamin antibodies inhibited the cellular uptake of cholera toxin B conjugates, provide strong support for the morphological data showing an accumulation of caveolae in these cells. Together, these results indicate that Dyn2 participates in caveola-mediated endocytosis. Our results are consistent with the observations of others who have shown that cholera toxin B is endocytosed via caveolae and trafficked to endosomes (Montesano et al., 1982; Tran et al., 1987; Parton, 1994); the Golgi apparatus (Joseph et al., 1979; Sandvig et al., 1994); and, under certain conditions, elements of the endoplasmic reticulum (Sandvig et al., 1996). Although in the latter study thapsigargin was used to induce movement to this compartment, the cultured hepatocytes used in this study apparently transport substantial amounts of the conjugated toxin back to the endoplasmic reticulum and the nuclear envelope during a 2.5-h incubation. This caveola-mediated endocytosis was much slower than clathrin- mediated endocytosis. In uninjected and control-injected cells, incubations of 1–2 h were required to accumulate the cholera toxin B conjugates intracellularly, whereas only 5–15 min were necessary to internalize the fluorescent conjugates of transferrin. Regardless, both of these endocytic processes were inhibited equally by the injected anti-dynamin antibodies. Electron microscopy revealed that in the anti-dynamin antibody-injected hepatocytes, HRP–cholera toxin B was concentrated in caveolar profiles at the plasma membrane. Because the cultured hepatocytes used in this study express caveolin, we are confident in identifying these small plasmalemmal invaginations as caveolae. In support of this, we have shown that the anti-Pan61 antibody immunoisolates caveolin-containing membranes directly and not by an indirect association with the plasma membrane. Furthermore, using this same antibody and an anti-caveolin antibody we have performed double label immunofluorescence microscopy of cultured hepatocytes to show that dynamin localizes to caveolae. Thus, we have concluded that anti-dynamin antibodies inhibit caveola-mediated processes based on multiple criteria: first, the characteristic shape and size of the accumulated structures; second, the fact that toxin-containing invaginations are not clathrin-coated and that toxin conjugates are internalized normally when clathrin-mediated endocytosis is inhibited by potassium depletion; third, the distinct time frame in which ligands for clathrin-mediated and caveola-mediated pathways are internalized; fourth, results from the immunoisolation experiments and double label immunofluorescence microscopy that indicate that dynamin associates directly with caveolae; and fifth, and most importantly, the numerous careful studies published by others demonstrating the internalization of cholera toxin by caveolae (Montesano et al., 1982; Tran et al., 1987; Parton, 1994; Schnitzer et al., 1996). Finally, our results are consistent with those of Schnitzer and coworkers (Oh et al., 1998), who have used an in vitro assay to demonstrate that a dynamin-depleted cytosolic fraction does not support the severing of caveolae from isolated plasma membrane fractions until additional exogenous dynamin is added back to the assay.
Before this study, the answer to whether dynamin participated in endocytic pathways other than clathrin-mediated endocytosis was not clear (see Artalejo et al., 1995; Urrutia et al., 1997). Observations from cells of the shibirets1 mutants indicate that fluid-phase endocytosis is completely inhibited at the restrictive temperature (Kessel et al., 1989; Kosaka and Ikeda, 1983a,b). Studies of transfected epithelial cells overexpressing a mutant Dyn1 isoform, however, have indicated that dynamin functions in clathrin-mediated endocytosis specifically and not in other forms of fluid-phase endocytosis (Damke et al., 1994, 1995; Herskovitz et al., 1993). In fact, fluid-phase endocytosis actually was upregulated in these cells in response to the inhibition of clathrin-mediated endocytosis (Damke et al., 1995). Significantly, like the shibire gene mutation, we have found that the anti-dynamin antibodies used in this study inhibit fluid-phase endocytosis in mammalian cells (Henley, J.R., and M.A. McNiven, manuscript in preparation) in addition to their effect on clathrin- and caveola-mediated endocytosis. Because of alternative splicing of the mRNA, Dyn2 is expressed as at least four isoenzymes in epithelial cells; therefore, it is possible that the microinjected anti-dynamin antibodies are inhibiting dynamin isoforms that an overexpressed mutant Dyn1 isoform would not. Certainly, defining the precise dynamin isoforms which participate in these distinct endocytic processes will prove interesting.
| Acknowledgments |
|---|
Submitted: 8 July 1997
Revised: 1 December 1997
J.R. Henley is the recipient of an American Liver Foundation Student Research Fellowship. This work was supported by National Institutes of Health grants to M.A. McNiven.
| References |
|---|
|
|
|---|
Anderson RGW. Caveolae: where incoming and outgoing messengers meet, Proc Natl Acad Sci USA, 1993a, 90, 10909–10913.
Anderson RGW. Plasmalemmal caveolae and GPI-anchored membrane proteins, Curr Opin Cell Biol, 1993b, 5, 647–652.[Medline]
Anderson RGW. Potocytosis of small molecules and ions by caveolae, Trends Cell Biol, 1993c, 3, 69–72.[Medline]
Anderson RGW, Brown MS & Goldstein JL. Role of the coated endocytic vesicle in the uptake of receptor bound low density lipoprotein in human fibroblasts, Cell, 1977, 10, 351–364.[Medline]
Anderson RGW, Kamen BA, Rothberg KG & Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae, Science, 1992, 255, 410–411.
Artalejo CR, Henley JR, McNiven MA & Palfrey HC. Rapid endocytosis coupled to exocytosis in adrenal chromaffin cells involves Ca2+, GTP and dynamin but not clathrin, Proc Natl Acad Sci USA, 1995, 92, 8328–8332.
Brown DA & Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface, Cell, 1992, 68, 533–544.[Medline]
Bundgaard M, Frøkjaer-Jensen J & Crone C. Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface, Proc Natl Acad Sci USA, 1979, 76, 6439–6442.
Carter LL, Redelmeier TE, Woollenweber LA & Schmid SL. Multiple GTP-binding proteins participate in clathrin-coated vesicle-mediated endocytosis, J Cell Biol, 1993, 120, 37–45.
Chen MS, Obar RA, Schroeder CC, Austin TW, Poodry CA, Wadsworth SC & Vallee RB. Multiple forms of dynamin are encoded by shibire, a Drosophilagene involved in endocytosis, Nature, 1991, 351, 583–586.[Medline]
Cook TA, Urrutia R & McNiven MA. Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues, Proc Natl Acad Sci USA, 1994, 91, 644–648.
Cook T, Mesa K & Urrutia R. Three dynamin-encoding genes are differentially expressed in developing rat brain, J Neurochem, 1996, 67, 927–931.[Medline]
Critchley DR, Streuli CH, Kellie S & Patel B. Characterization of the cholera toxin receptor on BALB/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity, Biochem J, 1982, 204, 209–219.[Medline]
Damke H, Baba T, Warnock DE & Schmid SL. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation, J Cell Biol, 1994, 127, 915–934.
Damke H, Baba T, van der Bliek AM & Schmid SL. Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin, J Cell Biol, 1995, 131, 69–80.
De Camilli P, Takei K & McPherson PS. The function of dynamin in endocytosis, Curr Opin Neurobiol, 1995, 5, 559–565.[Medline]
Dupree P, Parton RG, Raposo G, Kurzchalia TV & Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells, EMBO (Eur Mol Biol Organ) J, 1993, 12, 1597–1605.[Medline]
Fiedler K, Kobayashi T, Kurzchalia TV & Simons K. Glycosphingolipid-enriched detergent-insoluble complexes in protein sorting in epithelial cells, Biochemistry, 1993, 32, 6365–6373.[Medline]
Fishman PH. Internalization and degradation of cholera toxin by cultured cells: relationship to toxin action, J Cell Biol, 1982a, 93, 860–865.
Fishman PH. Role of membrane gangliosides in the binding and action of bacterial toxins, J Membr Biol, 1982b, 69, 85–97.[Medline]
Fra AM, Williamson E, Simons K & Parton RG. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin, Proc Natl Acad Sci USA, 1995, 92, 8655–8659.
Frøkjaer-Jensen J, Wagner RC, Andrews SB, Hagman P & Reese TS. Three-dimensional organization of the plasmalemmal vesicular system in directly frozen capillaries of the rete mirabile in the swim bladder of the eel, Cell Tissue Res, 1988, 254, 17–24.[Medline]
Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae, J Cell Biol, 1993, 120, 1147–1157.
Glenney JR & Zokas L. Novel tyrosine kinase substructures from Rous sarcoma virus-transformed cells are present in the membrane skeleton, J Cell Biol, 1989, 108, 2401–2408.
Glenney JR & Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts, Proc Natl Acad Sci USA, 1992, 89, 10517–10521.
Goldstein JL, Anderson RGW & Brown MS. Coated pits, coated vesicles and receptor mediated endocytosis, Nature, 1979, 297, 678–685.
Goldstein JL, Brown MS, Anderson RGW, Russell DW & Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system, Annu Rev Cell Biol, 1985, 1, 1–39.[Medline]
Grigliatti TA, Hall L, Rosenbluth R & Suzuki DT. Temperature-sensitive mutations in Drosophila melanogasterXV: a selection of immobile adults, Mol Gen Genet, 1973, 120, 107–114.[Medline]
Henley JR & McNiven MA. Association of a dynamin-like protein with the Golgi apparatus in mammalian cells, J Cell Biol, 1996, 133, 761–775.
Herskovits JS, Burgess CC, Obar RA & Vallee RB. Effects of mutant rat dynamin on endocytosis, J Cell Biol, 1993, 122, 565–578.
Hopkins CR & Trowbridge IS. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells, J Cell Biol, 1983, 97, 508–521.
Howell, K.E., R. Schmid, J. Ugelstad, and J. Gruenberg. 1989. Immunoisolation using magnetic solid supports: subcellular fractionation for cell-free functional studies. In Methods in Cell Biology. A.M. Tartakoff, editor. Academic Press, San Diego, CA. 265–292.
Huet C, Ash JF & Singer SJ. The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblasts, Cell, 1980, 21, 429–438.[Medline]
Jollie WP & Triche TJ. Ruthenium labeling of micropinocytotic activity in the rat visceral yolk-sac placenta, J Ultrastruct Res, 1971, 35, 541–553.[Medline]
Jones SM, Howell KE, Henley JR, Cao H & McNiven MA. Role of dynamin in the formation of transport vesicles from the trans-Golgi network, Science, 1998, 279, 573–577.
Joseph KC, Stieber A & Gonatas NK. Endocytosis of cholera toxin in GERL-like structures of murine neuroblastoma cells pretreated with GM1 ganglioside, J Cell Biol, 1979, 81, 543–554.
Kartenbeck J, Stukenbrok H & Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum, J Cell Biol, 1989, 109, 2721–2729.
Kessell I, Holst BD & Roth TF. Membranous intermediates in endocytosis are labile, as shown in a temperature-sensitive mutant, Proc Natl Acad Sci USA, 1989, 86, 4968–4972.
Koenig JH & Ikeda K. Disappearance and reformation of synaptic vesicle membrane upon transmitter release observed under reversible blockage of membrane retrieval, J Neurosci, 1989, 9, 3844–3860.[Abstract]
Koenig JH & Ikeda K. Transformational process of the endosomal compartment in nephrocytes of Drosophila melanogaster. , Cell Tissue Res, 1990, 262, 233–244.[Medline]
Kosaka T & Ikeda K. Possible temperature-dependent blockage of synaptic vesicle recycling induced by a single gene mutation in Drosophila. , J Neurobiol, 1983a, 14, 207–225.[Medline]
Kosaka, T., and K. Ikeda. 1983b. Reversible blockage of membrane retrieval and endocytosis in the garland cell of the temperature-sensitive mutant of Drosophila melanogaster, shibirets1. J. Cell Biol. 97:499–507.
Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M & Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi network–derived transport vesicles, J Cell Biol, 1992, 118, 1003–1014.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 1970, 227, 680–685.[Medline]
Larkin JM, Brown MS, Goldstein JL & Anderson RG. Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts, Cell, 1983, 33, 273–285.[Medline]
Larkin JM, Donzell WC & Anderson RG. Modulation of intracellular potassium and ATP: effects on coated pit function in fibroblasts and hepatocytes, J Cell Physiol, 1985, 124, 372–378.[Medline]
Lamaze C & Schmid SL. The emergence of clathrin-independent pinocytic pathways, Curr Opin Cell Biol, 1995, 7, 573–580.[Medline]
Lisanti MP, Scherer PE, Tang Z-L & Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis, Trends Cell Biol, 1994, 4, 231–235.[Medline]
Montesano R, Roth J, Robert A & Orci L. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins, Nature, 1982, 296, 651–653.[Medline]
Nakata T, Iwamoto A, Noda Y, Takemura R, Yoshikura H & Hirokawa N. Predominant and developmentally regulated expression of dynamin in neurons, Neuron, 1991, 7, 461–469.[Medline]
Nakata T, Takemura R & Hirokawa N. A novel member of the dynamin family of GTP-binding proteins is expressed specifically in the testis, J Cell Sci, 1993, 105, 1–5.[Abstract]
Obar RA, Collins CA, Hammarback JA, Shpetner HS & Vallee RB. Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins, Nature, 1990, 347, 256–261.[Medline]
Oh P, McIntosh DP & Schnitzer JE. Dynamin at the neck caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium, J Cell Biol, 1998, 141, 101–114.
Palade GE & Bruns RR. Structural modulation of plasmalemmal vesicles, J Cell Biol, 1968, 37, 633–649.
Parton RG. Ultrastructural localization of gangliosides; GM1is concentrated in caveolae, J Histochem Cytochem, 1994, 42, 155–166.[Abstract]
Parton RG. Caveolae and caveolins, Curr Opin Cell Biol, 1996, 8, 542–548.[Medline]
Parton RG & Simons K. Digging into caveolae, Science, 1995, 269, 1398–1399.
Parton RG, Joggerst B & Simons K. Regulated internalization of caveolae, J Cell Biol, 1994, 127, 1199–1215.
Patek PQ, Collins JL & Cohn M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis, Nature, 1978, 276, 510–511.[Medline]
Pearse BMF & Robinson MS. Clathrin, adaptors and sorting, Annu Rev Cell Biol, 1990, 6, 151–171.[Medline]
Peters K-R, Carley W & Palade GE. Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure, J Cell Biol, 1985, 101, 2233–2238.
Poodry CA & Edgar L. Reversible alteration in the neuromuscular junctions of Drosophila melanogaster bearing a temperature-sensitive mutation, shibire. , J Cell Biol, 1979, 81, 520–527.
Predescu D, Horvat R, Predescu S & Palade GE. Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide, Proc Natl Acad Sci USA, 1994, 91, 3014–3018.
Predescu SA, Predescu DN & Palade GE. Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium, Am J Physiol, 1997, 41, 937–949.
Robinson MS. The role of clathrin, adaptors and dynamin in endocytosis, Curr Opin Cell Biol, 1994, 6, 538–544.[Medline]
Robinson PJ, Liu J-P, Powell KA, Fykse EM & Südhof TC. Phosphorylation of dynamin I and synaptic-vesicle recycling, Trends Neurosci, 1994, 17, 348–353.[Medline]
Rothberg KG, Heuser JE, Donzell WC, Ying Y-S, Glenney JR & Anderson RGW. Caveolin, a protein component of caveolae membrane coats, Cell, 1992, 68, 673–682.[Medline]
Sager PR, Brown PA & Berlin RD. Analysis of transferrin recycling in mitotic and interphase HeLa cells by quantitative fluorescence microscopy, Cell, 1984, 39, 275–282.[Medline]
Sandvig K, Ryd M, Garred O, Schweda E, Holm PK & van Deurs B. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP, J Cell Biol, 1994, 126, 53–64.
Sandvig K & van Deurs B. Endocytosis without clathrin, Trends Cell Biol, 1994, 4, 275–277.[Medline]
Sandvig K, Garred O & van Deurs B. Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum, Proc Natl Acad Sci USA, 1996, 93, 12339–12343.
Scaife R & Margolis RL. Biochemical and immunochemical analysis of rat brain dynamin interaction with microtubules and organelles in vivo and in vitro, J Cell Biol, 1990, 111, 3023–3033.
Schnitzer JE, Oh P, Pinney E & Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules, J Cell Biol, 1994, 127, 1217–1232.
Schnitzer JE, McIntosh DP, Dvorak AM, Liu J & Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins, Science, 1995a, 269, 1435–1439.
Schnitzer JE, Oh P, Jacobson BS & Dvorak AM. Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca (2+)-ATPase, and inositol trisphosphate receptor, Proc Natl Acad Sci USA, 1995b, 92, 1759–1763.
Schnitzer JE, Oh P & McIntosh DP. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes, Science, 1996, 274, 239–242.
Severs NJ. Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? , J Cell Sci, 1988, 90, 341–348.
Shpetner HS & Vallee RB. Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules, Cell, 1989, 59, 421–432.[Medline]
Shupliakov O, Low P, Grabs D, Gad H, Chen H, David C, Takei K, De Camilli P & Brodin L. Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions, Science, 1997, 276, 259–263.
Shyjan AW & Levenson R. Antisera specific for the alpha 1, alpha 2, alpha 3, and beta subunits of the Na,K-ATPase: differential expression of alpha and beta subunits in rat tissue membranes, Biochemistry, 1989, 28, 4531–4535.[Medline]
Smart EJ, Foster DC, Ying Y-S, Kamen BA & Anderson RGW. Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae, J Cell Biol, 1994, 124, 307–313.
Smart EJ, Ying Y-S & Anderson RGW. Hormonal regulation of caveolae internalization, J Cell Biol, 1995, 131, 929–938.
Sontag J-M, Fykse EM, Ushkaryov Y, Liu J-P, Robinson PJ & Südhof TC. Differential expression and regulation of multiple dynamins, J Biol Chem, 1994, 269, 4547–4554.
Stang E, Kartenbeck J & Parton RG. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae, Mol Biol Cell, 1997, 8, 47–57.[Abstract]
Takei K, McPherson PS, Schmid SL & De Camilli P. Tubular membrane invaginations coated by dynamin rings are induced by GTP-
S in nerve terminals, Nature, 1995, 374, 186–190.[Medline]
Towbin H, Staehelin T & Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc Natl Acad Sci USA, 1979, 76, 4350–4354.
Tran D, Carpentier JL, Sawano F, Gorden P & Orci L. Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway, Proc Natl Acad Sci USA, 1987, 84, 7957–7961.
Urrutia R, Henley JR, Cook T & McNiven MA. The dynamins: Redundant or distinct functions for an expanding family of related GTPases? , Proc Natl Acad Sci USA, 1997, 94, 377–384.
Vale RD, Reese TS & Sheetz MP. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility, Cell, 1985, 42, 39–50.[Medline]
van der Bliek AM & Meyerowitz EM. Dynamin-like protein encoded by the Drosophila shibiregene associated with vesicular traffic, Nature, 1991, 351, 411–414.[Medline]
van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM & Schmid SL. Mutations in human dynamin block an intermediate stage in coated vesicle formation, J Cell Biol, 1993, 122, 553–563.
van Deurs N, Holm PK, Sandvig K & Hansen SH. Are caveolae involved in endocytosis? , Trends Cell Biol, 1993, 3, 241–249.
Warnock DE & Schmid SL. Dynamin GTPase, a force-generating molecular switch, BioEssays, 1996, 18, 885–893.[Medline]
Watts C & Marsh M. Endocytosis: what goes in and how, J Cell Sci, 1992, 103, 1–8.
Yamada E. The fine structure of the gall bladder epithelium of the mouse, J Biophys Biochem Cytol, 1955, 1, 445–458.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|